Duke’s Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have faked several analyses of chemotherapy and cancer, has resigned from the university. The Duke Chronicle reports that Potti …stepped down from his position at Duke’s Institute for Genome Sciences and Policy Friday and took responsibility for the … Continue reading Duke’s Anil Potti resigns
The title of this post is stolen, with adoring attribution, from a piece in the November 16, 2010 issue of Autophagy, because we couldn’t have said it better ourselves. In the piece, the journal’s editor, Dan Klionsky, focuses on images. It reads, in part:
We have a follow-up to our post two weeks ago about a possible retraction in the case of Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have also faked an analysis of how breast cancer responds to chemotherapy. In that post, we noted that the Raleigh News … Continue reading JCO makes it official, retracting paper co-authored by Anil Potti
The title of this post is a question that we’ve been asking ourselves since we started Retraction Watch in August, and that others have asked us since. And we’ve gotten different answers depending where we look: In our first post, we cited a study that found 328 retractions in Medline in the decade from 1995 … Continue reading So how many retractions are there every year, anyway?
It’s a busy week at Science. The journal is retracting a controversial paper about which it had previously expressed doubts, and has published an “Expression of Concern” about another article that looks like it might be headed for the same fate. First, the retraction. The move involves an October 2009 paper, on which we’ve previously … Continue reading Science plays two — a retraction, and concern issued about genetics papers
Both Retraction Watch bloggers are all too familiar with the artwork in dermatology journals. One of us, AM, used to write for Skin & Aging, while the other, IO, waited eagerly for issues of Cutis sent to his pediatrician father to show up on the coffee table. And IO recently broke the incredibly important story … Continue reading Warts and all: Derm pub retracts plantar paper after author cries foul
One of the world’s leading cancer researchers, Axel Ullrich of Germany, has retracted two papers published in the Journal of Biological Chemistry. Ullrich, director of microbiology at the Max Planck Institute of Biochemistry, has been a central figure in many groundbreaking discoveries, from the development of genetically engineered insulin to the identification of the breast … Continue reading Leading cancer scientist retracts two papers, one 14 years old, but journal won’t say why
Amy Wagers, a Harvard stem cell researcher, retracted a Nature study last week and has another published paper under scrutiny at Blood. Retraction Watch has now learned that a 2008 Cell paper she co-authored drew significant criticism from a stem cell researcher at Children’s National Medical Center. In the paper, Wagers and her team said … Continue reading Scientist raised serious questions about 2008 Cell study by Amy Wagers
Last week’s big Retraction Watch news — which got us quoted in the New York Times — was a Nature paper by Amy Wagers and Shane Mayack. The now-retracted paper suggested that the aging of stem cells could be reversed, and Blood has issued a notice of concern about a second paper. Now comes news … Continue reading Another stem cell paper retracted, for “breach of established ethical guidelines”
Yesterday, we noted that Amy Wagers and Shane Mayack have published five papers together. One of those, published earlier this year in Nature, was retracted Wednesday, and another is now the subject of a “notice of concern” from Blood. We wanted to find out about some of the other papers published by Wagers and Mayack, … Continue reading Editor of another journal where Wagers and Mayack published an abstract is monitoring the situation